Artrya

Performance

About Artrya

Artrya is a healthcare company that uses AI-driven analysis of coronary computed tomography angiography (CCTA) to detect and quantify arterial plaque, enabling rapid risk stratification for chest pain patients. It partners with clinics to integrate plaque features into cardiovascular evaluation and aims to reduce unnecessary testing and hospital admissions by guiding evidence-based decisions. Based in Australia with a focus on the U.S. market and other jurisdictions, Artrya emphasizes precise diagnosis and personalized treatment in emergency and primary care settings.